|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CLINICAL STUDY |
1 Department of Paediatric Endocrinology, Hôpital des Enfants, Toulouse, France2 Department of Endocrinology, Hôpital Larrey, Toulouse, France3 , Department of Biology4 INSERM U563, Department of Lipoprotéines et Médiateurs Lipidiques, Hôpital Purpan, Toulouse, France
(Correspondence should be addressed to M Tauber; Email: tauber.mt{at}chu-toulouse.fr)
Background/aims: Primary IGF1 deficiency (IGFD) is defined by low levels of IGF1 without a concomitant impairment in GH secretion in the absence of secondary cause. The aims of this study were to evaluate the prevalence of non-GH deficient IGFD in prepubertal children with isolated short stature (SS) and to describe this population.
Methods: This retrospective study included all children with isolated SS seen in our Pediatric Endocrinology Unit from January 2005 to December 2007. Children were included based on the following criteria: i) SS with current height SDS
–2.5, ii) age
2 years, and iii) prepubertal status. Exclusion criteria were: i) identified cause of SS and ii) current or past therapy with rhGH. IGF1-deficient children were defined as children without GH deficiency and with IGF1 levels below or equal to –2 SDS.
Results: Among 65 children with isolated SS, 13 (20%) had low IGF1 levels, consistent with a diagnosis of primary IGFD, four of which were born small for gestational age and nine were born appropriate for gestational age. When compared with non-IGFD children, IGFD children had higher birth weight (–0.7 vs –1 SDS, P=0.02) and birth height (–1.7 vs –2 SDS, P=0.04) and more delayed bone age (2.6 vs 1.7 years, P=0.03).
Conclusion: The prevalence of primary IGFD was 20% in children with isolated SS. Concerning the pathophysiology, our study emphasizes that IGFD in some children may be secondary to nutritional deficiency or to maturational delay.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |